MUMBAI Nov 5 Cipla Ltd, India's third-largest drugmaker by sales, reported a second-quarter net profit slightly below analysts estimates, as expenses rose.
Net profit rose 44 percent to 4.31 billion rupees ($65.56 million) in the quarter ended September, Cipla said in a statement on Thursday. But it was below analysts' average estimate of 4.84 billion rupees, according to Thomson Reuters data.
19:08 U.S. indicts three Takata executives, fines company $1 billion in faulty air bag scandal15
13:48 Wells Fargo Profit Falls 5.4% as Mortgage Revenue Declines23
12:08 Bank of America Profit Rises 43% on Trading Gains, Cost Cuts22
12:02 Bank of America tops earnings forecast, predicts 'significant increase' in net interest income20